Navigation Links
Quest Diagnostics to Speak at the 20th Annual Piper Jaffray Healthcare Conference
Date:12/2/2008

MADISON, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Piper Jaffray Healthcare Conference in New York City today, December 2, 2008. The Quest Diagnostics presentation is scheduled to begin at 4:00 p.m. Eastern Time.

During the conference, the company will reaffirm its 2008 guidance for revenue growth of greater than 8%, operating income to approach 17% of revenues, and adjusted earnings per diluted share from continuing operations of between $3.17 and $3.22. This guidance excludes the impact of a third quarter equity investment write-down and hurricanes.

The presentation will be webcast live during the conference and will be available to registered investors on the following site: http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=DGX&item_id=1981734 (due to the length of the URL, please copy and paste into your browser)and to the public on www.QuestDiagnostics.com/investor. In addition, the archived webcast will be available approximately one hour after the conclusion of the live event and will remain available until January 1, 2009.

Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at: www.QuestDiagnostics.com.


'/>"/>
SOURCE Quest Diagnostics Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. SimQuest Awarded Phase 2 Contract from Office of the Secretary of Defense to Develop Pandemic Influenza Training Program
2. Long-term antibiotics reduce COPD exacerbations, raise questions
3. Use of Mini Dental Implants on the Rise but Questions Linger
4. NutritionQuests Alive! Program Improves Quality of Life
5. Urgent Request for Water
6. CAGW Questions Healthcare Plan Options Presented to the Dougherty County Commission
7. Doctors questions about end-of-life legalities may result in patient pain
8. TheraQuests IND for Abuse Deterrent Strong Opioid (TQ-1015) Accepted by FDA
9. Ski Safety and Medical Experts, Victims of Snow Sport Tragedies and Consumers Shed Light on Questionable Safety Practices of California Ski Resorts
10. Millions Follow Erik Comptons Quest to Win a PGA TOUR Card and Build Awareness for Organ Donation
11. Study Questions Screening Heart Attack Patients for Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading provider of ... that Kyle Allain has joined the company as Vice President and General Manager ... provider, payor and managed care solutions. , A seasoned executive with more ...
(Date:4/24/2017)... ... April 24, 2017 , ... In ... be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research into ... this type of healthcare model in the diagnosis and treatment of brain tumors. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Rod Burkett, CEO of Gardant ... website. , Rod has been at the forefront of Gardant since it was founded ... Rod has overseen the opening of more than 40 new senior living communities. With ...
(Date:4/24/2017)... ... April 24, 2017 , ... As a former supermodel known for her ... good news for single women is that she put all the words in her ... 25th. Joan's insight, personal experiences and sparkling sense of humor have inspired her to ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... familiar. This makes it difficult for lab operators and management to assess these ... help them identify wasteful or unnecessary actions. , Created with the help ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: